ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,777Medicare Part D Prescriptions Filled, Including Refills

Rank: 751 out of 2343

$493K Total Retail Price of All Prescriptions

Rank: 688 out of 2343

381 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 381 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 381 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 7,275 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 392 364 1 1
LISINOPRIL 330 298 2 3
LEVOTHYROXINE SODIUM 291 288 3 2
FUROSEMIDE 282 270 4 6
ATENOLOL 274 258 5 12
AMLODIPINE BESYLATE 246 239 6 5
OMEPRAZOLE 186 178 7 4
METOPROLOL TARTRATE 166 165 8 7
ATORVASTATIN CALCIUM 158 149 9 10
METOPROLOL SUCCINATE 134 129 10 14
CITALOPRAM HBR 124 109 11 17
PANTOPRAZOLE SODIUM 123 110 12 22
WARFARIN SODIUM 114 109 13 8
LOSARTAN POTASSIUM 113 112 14 19
PRAVASTATIN SODIUM 111 98 15 15
HYDROCHLOROTHIAZIDE 111 106 15 11
METFORMIN HCL 98 82 17 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 94 94 18 42
CRESTOR 93 93 19 30
ZOLPIDEM TARTRATE 92 91 20 24
POTASSIUM CHLORIDE 89 89 21 18
LOVASTATIN 84 84 22 47
ALENDRONATE SODIUM 78 75 23 28
LOSARTAN-HYDROCHLOROTHIAZIDE 76 66 24 64
CLOPIDOGREL 76 69 24 26
TRAMADOL HCL 71 71 26 25
PLAVIX 68 64 27 38
GABAPENTIN 68 59 27 16
NEXIUM 67 58 29 33
GLIMEPIRIDE 67 65 29 45
ISOSORBIDE MONONITRATE ER 65 65 31 32
ZETIA 60 57 32 52
DIGOXIN 54 54 33 35
ENALAPRIL MALEATE 53 42 34 58
ALLOPURINOL 51 47 35 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 31, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.